Strides Arcolab shares sink on dividend worries
MUMBAI (Reuters) - Shares in drugmaker Strides Arcolab (STAR.NS) plummeted about 10 percent on Thursday, wiping out early gains following its sale of a unit to Mylan (MYL.O) for $1.6 billion, as investors were unhappy with Strides' dividend payout, traders said.
The shares had initially gained as much as 13.2 percent.
The company declared a 20 percent dividend, or 2 rupees per share, for 2012.
Strides' injectables unit Agila Specialties generated $700 million in sales and an operating profit of $86 million in year 2012, Strides said.
The Bangalore-based drugmaker said it planned to spend $700 million to $800 million at pretax level on shareholders.
Valued at $1.1 billion, shares in Strides Arcolab were down 8.5 percent at 902.95 rupees by 9:51 a.m. when the Mumbai market was up 0.55 percent.
(Reporting by Kaustubh Kulkarni; Editing by Gopakumar Warrier)
- Tweet this
- Share this
- Digg this
- Israel intensifies Gaza assault, Egyptians revise truce plan
- UPDATE 6-U.S. judge says cannot seize Kurdish crude for now
- UPDATE 2-EU agrees economic sanctions on Russia
- UPDATE 4-Obama says strains over Ukraine not leading to new Cold War with Russia
- Family of Texas doctor with Ebola not showing signs of virus
Top Indian mobile carrier Bharti Airtel posted a 61 percent rise in quarterly profit on Tuesday but fell short of analyst estimates as its African business continued to weigh. Full Article
Finmeccanica settles with Italy prosecutors to end Indian chopper deal probe. Full Article